{"schema_version":"1","generated_at":"2026-11-14T19:36:40.538Z","data_as_of":null,"url":"https://www.findmykol.com/kol/joseph-dottino","json_url":"https://www.findmykol.com/kol/joseph-dottino/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"joseph-dottino","name":"Joseph Dottino","specialty":"Obstetrics & Gynecology","specialty_raw":"Obstetrics & Gynecology","therapeutic_area":"Gynecologic","therapeutic_areas":["Gynecologic"],"city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1457618118","orcid":"0000-0002-1199-7825","openalex":"A5055019053"},"summary":"Joseph Dottino is a Gynecologic physician. OpenAlex indexes 59 publications with 508 citations (h-index 11).","overview":null,"focus":{"indications":[],"research_topics":["Gynecologic"]},"scholarship":{"works_count":59,"cited_by_count":508,"h_index":11,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2024,"amount_usd":33.63,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1457618118"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1457618118","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Impact of GLP-1 RA plus progestin therapy on fertility-sparing management of endometrial intraepithelial neoplasia and endometrial cancer","year":2026,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2026.03.010","status":"verified"},{"title":"Trends in use of poly (ADP-ribose) polymerase inhibitor (PARPi) in ovarian cancer","year":2026,"journal":"Cancer Epidemiology","source_url":"https://doi.org/10.1016/j.canep.2026.102996","status":"verified"},{"title":"Trends in use of glucagon-like peptide-1 receptor agonists in obese patients with endometrial cancer","year":2026,"journal":"SSRN Electronic Journal","source_url":"https://doi.org/10.2139/ssrn.7266806","status":"verified"},{"title":"Trends in time from diagnosis to initiation of chemoradiation in cervical cancer in the United States: A national cancer database analysis","year":2026,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2026.01.231","status":"verified"},{"title":"Time toxicity of frontline maintenance poly (ADP-ribose) polymerase inhibitor use in ovarian cancer","year":2026,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2026.01.532","status":"verified"}],"source":"works"},"similar":[{"name":"Anil Sood","slug":"anil-sood","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/anil-sood","json_url":"https://www.findmykol.com/kol/anil-sood/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"},{"name":"Robert Bast","slug":"robert-bast","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/robert-bast","json_url":"https://www.findmykol.com/kol/robert-bast/profile.json"},{"name":"Baha Sibai","slug":"baha-sibai","institution":"McGovern Medical School at UTHealth Houston","specialty":"Maternal & Fetal Medicine","url":"https://www.findmykol.com/kol/baha-sibai","json_url":"https://www.findmykol.com/kol/baha-sibai/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}